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Abstract
Nanoscale organisation of receptor ligands has become an important approach to study the 
clustering behaviour of cell-surface receptors. Biomimetic substrates fabricated via different 
nanopatterning strategies have so far been applied to investigate specific integrins and cell types, 
but without multivalent control. Here we use DNA origami to surpass the limits of current 
approaches and fabricate nanoarrays to study different cell adhesion processes, with nanoscale 
spatial resolution and single-molecule control. Notably, DNA nanostructures enable the display of 
receptor ligands in a highly customisable manner, with modifiable parameters including ligand 
number, ligand spacing and most importantly, multivalency. To test the adaptability and robustness 
of the system we combined it with focused ion beam and electron-beam lithography nanopatterning 
to additionally control the distance between the origami structures (i.e. receptor clusters). Moreover, 
we demonstrate how the platform can be used to interrogate two different biological questions: 1) 
the cooperative effect of integrin and growth factor receptor in cancer cell spreading, and 2) the 
role of integrin clustering in cardiomyocyte adhesion and maturation. Thereby we find previously 
unknown clustering behaviour of different integrins, further outlining the importance for such 
customisable platforms for future investigations of specific receptor organisation at the nanoscale.
Introduction
Mammalian cells are embedded in an extracellular matrix (ECM), composed of proteoglycans, 
glycosaminoglycans and glycoproteins. The ECM components serve as anchoring points for the 
cells, but binding of integrins and other cell surface receptors also induce cellular signalling 
cascades which regulate fundamental processes from cell growth, to differentiation, motility or cell 
death1. The contact interface between the ECM and cell-binding domains, depends on the receptors’ 
nanoscale spatial organisation2, 3 and clustering 4-7. Integrin-ECM interactions are also regulated by 
cellular (cytoskeletal) and extracellular forces (such as the passive stiffness of the ECM) that affect 
the stability of the bonds 1, 8-10. Importantly integrin clustering distributes the forces between the 
receptor-ligand complexes, increasing the maximum force per bond and enabling further integrin 
adhesion assembly 4-6, 9, 11. Additionally, it is known that integrins work synergistically with other 
membrane receptors to modulate cell behaviour 5, 12-14.
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Different strategies have been developed to fabricate biomimetic substrates for the investigation of 
ECM geometries in cell spreading and focal adhesion formation 6, 15-20. Achieving nanoscale control 
of adhesion receptors, with single molecule resolution, is essential for such investigations; micellar 
diblock copolymer self-assembly 21 and nanopatterning approaches 4, 17, 18, 22 have been the most 
notable strategies to meet this requirement. This has been achieved via the arrangement of metal 
nanodots in arrays and their use as tethering points for cell-binding domains. These studies 
demonstrated that in order to establish stable focal adhesions and initiate integrin clusters,  the 
examined cells (αvβ3 integrin rich fibroblast, osteoblast and cancer cells) require a preferential 
spacing of ∼60 nm between single RGD peptides3, 4, 6, 15. However, a recent study with 
peptidomimetic ligands indicated that major differences exist in the clustering behaviour between 
αvβ3 and α5β1 integrins23 and information about other integrin subtypes or from different cellular 
systems is lacking. Most importantly, these strategies have shown only partial application for 
multivalent investigations with single-molecule control 16, 19. 
In this regard, we recently presented a strategy for the fabrication of biomimetic nanoarrays, based 
on the use of DNA origami that permit the multivalent investigation of ligand-receptor molecule 
interactions (simultaneous binding of multiple different ligands) in cancer cell spreading with 
nanoscale spatial resolution and single-molecule control 20. Here we demonstrate the extension of 
this approach to different cell adhesion processes. Nanoscale spatial resolution and single-molecule 
control have been achieved by selectively functionalising DNA nanostructures with specific cell 
surface receptor ligands for human cutaneous melanoma cells and neonatal rat cardiomyocytes.  We 
combined this with both an electron-beam and focused ion beam nanopatterning approach to 
assemble DNA Origami in nanoarray configurations. The platforms so developed were then 
employed for cancer cell spreading investigations and to investigate cardiomyocyte attachment and 
maturity in response to different peptide configurations. This demonstrates the general applicability 
and validity of DNA origami nanoarrays as biomimetic substrates for the study of (multivalent) 
ligand−receptor interactions in the regulation of cellular adhesion and function, with nanoscale 
spatial resolution and single-molecule control.
Results and Discussion
Design of the arrays and nanostructures
Cellular adhesion to - and probing of - the extracellular environment involves recruitment, 
activation and clustering of integrins 1, 2, 11, 24. Sufficient ligand density is key for cell spreading and 
viability 6, 25, 26. For certain cell types and integrins (especially a αvβ3), the preferential ligand 
spacing required for spreading is 60 nm 4, 15, 22, but a recent study suggested that differences might 
exist between integrin subtypes23. However, the clustering behaviour of integrin subtypes in 
different cellular systems is still elusive. Furthermore, the role of the nanoscale organisation for the 
crosstalk between different cell surface receptors is not well understood. To address these 
challenges, we designed DNA origami nanostructures for two specific applications, namely the 
investigation of the cooperativity of growth factor and integrin signalling in cancer cells, as well as 
the role of integrin ligand spacing and densities in the regulation of cardiomyocyte function.  
For the cancer cell investigations, DNA origami were engineered and functionalised with 
A20FMDV2 peptides, selective for αvβ6 integrin subtypes, and epidermal growth factor (EGF). 
The αvβ6 integrin subtype is overexpressed in almost one third of carcinomas 27, correlates with 
poor cancer survival 28 and has been identified as a key marker for metastasis 29 via its modulation 
of proliferative signalling pathways 30. EGF receptors (EGFR) are known to work cooperatively 
with integrins and play a key role in regulating the signalling mechanisms at cell adhesion sites 31. 
EGFR is also upregulated in many cancers and together with integrins, regulates cancer cell 
proliferation, migration and metastasis 32. For this reason, the A20FMDV2 peptides and EGF were 
chosen for multivalent investigations of cooperative substrate bindings effects of αvβ6 integrins 
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and EGF (respectively) in human melanoma cells (A375P, human malignant cutaneous melanoma 
cell line). DNA origami were designed to present 6 peptides/EGF along their outer edges, at 60 nm 
intervals. 
To demonstrate the versatility of DNA origami substrate nanopatterning, we sought to extend this 
approach to the investigation of integrin clustering dynamics for primary neonatal rat 
cardiomyocytes (NRCs), which due to their contractile nature differ from other cell types in 
adhesion structure and cytoskeletal organisation10, 33. For this purpose, DNA origami were 
engineered to present the cyclic RGD (cRGDfC) peptide.  Neonatal cardiomyocytes contain 
relatively high levels of the RGD binding α5β1 integrin subtype which is downregulated shortly 
after birth (in exchange for laminin binding integrins), but is re-expressed in cardiomyocytes after 
myocardial infarction and in other cardiac diseases, where it is strongly associated with the  
activation of pathological signalling pathways 34. Because of the absence of αvβ3 integrin from 
NRCs, cRGDfC peptides were utilised to investigate the effect of ligand distance and density on 
α5β1 integrin clustering and downstream cardiomyocyte behaviour. DNA origami configurations 
of 6, 12 and 18 peptides were fabricated, constituting inter-peptide spacings of approximately 60 
nm, 30 nm and 20 nm (respectively) along the outer edge of each DNA origami structure.
Synthesis and Assembly of Functionalised DNA Origami Nanostructures.
To functionalise DNA origami with A20FMDV2 and cRGDfC, two different attachment 
chemistries were employed (Figure 1). A20FMDV2 was conjugated to ssDNA via a maleimide-
thiol reaction, bridging the cysteine thiol on the peptide and a deprotected maleimide on ssDNA (5’ 
end OH group of the phosphate). The cRFDfC peptides were conjugated to ssDNA with a 1 hour, 
UV mediated thiol-ene reaction35, via a sulfhydryl group on the peptide and a thiol group on ssDNA 
modified with an acrydite moiety. For all ssDNA-peptide products, Reverse-Phase High 
Performance Liquid Chromatography (RP-HPLC) was used to verify successful conjugation. Using 
this approach, the conjugation efficiency was estimated via the relative change in UV adsorption 
(260 nm) of the unconjugated ssDNA compared to the emerging conjugated product. Additional 
validation of the yield was obtained using a microvolume spectrophotometer (see methods). The 
maleimide conjugation approach produced a yield of ~63%, while the acrydite labelling method 
produced a near 100% yield (Supplementary Figure 1). Purified peptide-ssDNA conjugates were 
then hybridised to DNA origami in solution via complementary “sticky-end” strands incorporated 
into the design, enabling selective positioning of peptides on the origami structure with ~6 nm 
precision.
Individual EGF moieties were selectively positioned and attached to DNA origami via a 
streptavidin-biotin conjugation technique (Figures 1 and 2). ssDNA was modified to present the 
biotin which were firstly hybridised to the origami structure. Streptavidin modified EGF was then 
incubated in solution overnight to achieve successful conjugation to DNA origami structures.  
The successful design of both types of DNA nanostructures was further verified by casting diluted 
solution on muscovite mica substrates. Figure 2 shows atomic force microscopy (AFM) images of 
the triangular DNA origami employed in this study. 
Nanoscale Surface Lithography for Selective Positioning of Functionalised DNA Origami.
Combining nanoscale lithographic substrate fabrication and functionalised DNA origami presents 
a powerful tool for multivalent investigations into ligand-receptor clustering dynamics. 
Furthermore, the use of three peptide concentration (6, 12 and 18 peptides) and two DNA origami 
spacing configurations (200 nm and 300 nm spacing) permits unparalleled control over both local 
and global peptide concentration and stoichiometry at physiologically relevant sales (30-300 nm).
Two approaches were implemented to selectively position individual DNA origami over arrays of 
up to 3.68 mm2 using focussed ion beam (FIB) and electron-beam (EBL) lithography. The first 
approach implemented was a one-step FIB lithographic process (Figure 3) to fabricate holes in 
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metal-coated SiO2 substrates 20, 36. Chromium and gold were initially evaporated onto SiO2 
substrates to form 2 nm and 8 nm layers, respectively. Using FIB, 200 × 200 nm squares were milled 
into the metal, at 300 nm intervals. A 300 nm spacing per nanoaperture and therefore per DNA 
origami, was chosen for these nanoarrays to achieve a density of at least 87 ligands per μm2.20 The 
exposed SiO2 was then silanised with a carboxylic acid terminated silane through which origami 
were covalently cross-linked to the surface using an EDC/sulfo-NHS carbodiimide crosslinking 
reaction, and the amino modifications in the central void of the origami (Figure 3). The stability of 
the metallic surface offers a reusable, one-step fabrication of patterned arrays with the ability to 
selectively position single, functionalised DNA origami, with a yield of 82% ± 0.17 20.
The second approach utilised EBL to define the DNA origami bindings sites 37. Here, 150 nm in 
diameter holes were patterned in a hexamethyldisilazane layer (1-2 nm thickness) and poly(methyl 
methacrylate) (~100 nm thickness) resist at intervals of 200 or 300 nm, exposing the underlying 
SiO2 (Figure 3). Glass coverslips were patterned with a total of six, 1.5 × 1.5 mm nano-patterned 
areas (3 × 200 nm and 3 × 300 nm arrays). An isotropic oxygen plasma etch was then used to 
generate silanol groups in the holes which were correspondingly silanised with a carboxylic silane. 
DNA origami were then cross-linked to the surface via the same carbodiimide chemistry as above. 
While lacking the reusability of the FIB nanopattern, this approach offers the advantages of a higher 
yield of single DNA origami binding events (100% of sites filled, with  ca. 90 % single origami 
attachment) on transparent substrates. 
Multivalent Activation of EGF and αvβ6 Integrins in Human Cutaneous Melanoma Cells
To investigate the synergistic effect of integrin/EGF binding in cancer cell interaction with the 
ECM, human melanoma cells (A375P) were seeded on FIB nanopatterned substrates functionalised 
with DNA origami for 1.5 hours before fixation. The cooperative effects of αvβ6 integrin and EGF 
binding was evaluated by varying the ratio of A20FMDV2 peptides and EGF ligands (number of 
peptides:EGF: 1:1, 3:1 and 3:3). The degree of cell attachment and spreading was evaluated with 
phase contrast and immunofluorescence microscopy. Control experiments of blank FIB 
nanopatterns did not mediate the attachment of any cells. Melanoma cells adhered to all substrates 
but the degree of spreading, as indicated by phase images and phalloidin staining, was greater with 
increasing ligand density (see Figure 4). The EGF receptor (EGFR) sub-family of receptor tyrosine 
kinases has well validated roles in cancer progression and metastasis38. Immunofluorescence of 
phosphorylated tyrosines (pTyr) was therefore used as a marker of general tyrosine kinase activity, 
including EGFR activity. Figure 4 shows that the highly motile melanoma cell line A375Pb6 does 
not form strong focal adhesions on the origami. Moreover, the ratio of peptide:EGF dramatically 
changes cell signalling and cell behaviour.  At a peptide:EGF  ratio of 1:1 the cells are all well 
spread, actin is distributed diffusely and pTyr signalling is weak. When the ratio is peptide: EGF of 
3:1 the cells remain well spread, pTyr signalling increases and some cells show sub membranous 
actin on one side of the cell, consistent with potential development of a migratory leading edge. 
Interestingly, additional EGF ligands (peptide:EGF 3:3) reverses the cells to a more rounded 
phenotype and reduce the pTyr signalling.  These data show clearly that nanoscale modulation of 
ligand density of interactive membrane receptors can induce dramatic changes in cells that warrant 
more detailed investigations.
Peptide Functionalised DNA Origami Mediates Cell Adhesion and Spreading in Neonatal 
Rat Cardiomyocytes
To investigate integrin receptor clustering in primary neonatal rat cardiomyocyte (NRC) cultures 
we first tested the ability of the DNA origami to mediate cell attachment and spreading in a dose 
dependent manner on random, non-patterned arrays. DNA origami functionalised with 6, 12 and 
18 cRGDfC peptides per origami (corresponding to approximate peptide distances of 60, 30, and 
20nm, respectively) were cast randomly on 16 mm round glass coverslips and covalently cross-
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linked via the EDC/s-NHS carbodiimide chemistry described above. DNA origami without any 
peptides attached were used as a control. An optimum concentration of 2 nM DNA origami was 
used to achieve a uniform surface coverage of 10  3 DNA origami/µm2 (Figure 5). Surfaces were  ±
passivated with an methoxy PEG silane and blocked with 5% bovine serum albumin to minimise 
non-specific adhesion. NRCs were seeded on the substrates and cultured for 24 hours before the 
degree of NRC attachment, spreading and phenotype was evaluated. Compared to the 0-peptide 
control, the number of cells attached to the substrate and the degree of cell spreading increased 
when 12 or more peptides (30 nm distance between peptides, ~120  36 ligands/µm2) were present ±
on each DNA origami, however cells mainly displayed continuous filamentous instead of striated 
F-actin staining pattern, indicating an immature phenotype (Figure 5). When 18 peptides were 
present (180  54 ligands/µm2), a further increase in cell attachment and spreading was observed ±
and sarcomeric striations were clearly visible (see Supplementary Figure 2), thus confirming the 
ability of functionalised DNA origami to mediate cell attachment and verifying the successful 
synthesis of the different origami designs. 
Nanoscale Control of Global and Local Ligand Clustering Dynamics in Cardiomyocytes
Random positioning of peptide functionalised DNA origami demonstrated that a minimum of 12 
peptides per DNA origami (~120  36 ligands/µm2) were required to initiate cardiomyocyte ±
adhesion and spreading. However, random positioning of DNA origami provides no control over 
ligand geometry above the level of individual origami (~ 85 nm2) and offers limited information on 
global and local clustering dynamics, which are key for cell adhesion and spreading 5, 21. To 
investigate this, DNA origami functionalised with 0, 6 or 12 cRGDfC peptides were bound to EBL 
nanopatterned substrates at 200 nm and 300 nm intervals (Figure 5), and this allowed us to further 
investigate the role of cluster spacing, due to the differences in receptor clustering behaviour 
between cardiomyocytes and fibroblasts. EBL nanopatterned substrates were blocked against non-
specific adhesion with a methoxy PEG silane and 5% BSA before seeding NRCs for 24 hours. All 
cells adhered to the nanopattern were imaged and the degree of cell spreading and cytoskeletal 
maturity was evaluated by calculating cell area and F-actin intensity. On 0 peptide controls, a small 
degree of nonspecific cell adhesion was observed (Figure 6), although almost all NRCs were 
rounded up, presumably in a state of detachment. Negative controls of nanopattern without DNA 
origami did not facilitate any cardiomyocyte adhesion. Functionalised DNA origami with 6 
cRGDfC peptides (60 nm peptide spacing) resulted in the initiation of cell spreading when origami 
were spaced at 200 nm intervals (150 peptides/µm2), but not at 300 nm intervals (54 peptides/µm2); 
cell area at 200 nm intervals was measured to be (mean  SD) 599  178 µm2 compared to 442.5 ± ±
 125 µm2 at 300 nm intervals, equivalent to the area of rounded unspread cardiomyocytes. ±
Increasing the number of peptides to 12 per DNA origami (30 nm peptide spacing) resulted in a 
marked increase in cell attachment and clear initiation of spreading at both 300 nm (108 
peptides/µm2) and 200 nm (300 peptides/µm2) origami spacings, although differences in area, and 
F-actin content and organisation persisted (Figure 6). At 300 nm, cell area increased to 645  265 ±
µm2, although a sub-population of rounded cells were still observed. At 200 nm origami spacing, 
average cell area increased to 755  192 µm2 and almost all cells were spread, indicating stable ±
adhesion formation. 
This difference in spreading and F-actin content (Figure 6) depending on origami distance, while 
maintaining the same ligand spacing on the origami was surprisingly indicating that in contrast to 
fibroblasts, the density between the ligands is influencing cardiomyocyte adhesion. 60 nm has been 
reported to be the optimal spacing to form stable focal adhesions and initiate efficient cell spreading 
in fibroblasts, osteoblasts and cancer cell lines, which in contrast to NRCs all express high levels 
of αvβ3 integrins 4, 15, 21, 22, 26. However, the observed variation in cardiomyocyte spreading at both 
200 and 300 nm spacing is indicative of differences in adhesion formation between integrin 
subtypes in agreement with a previous study using peptidomimetic ligands23.
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Conclusions
Our results demonstrate the adaptability of biomimetic nanoarray platforms based on the use of 
DNA origami to study spreading and adhesion of different cell types. We show that DNA 
nanostructures conjugated to receptor ligands can be placed with high efficiency and precision onto 
nanopatterns fabricated with different methods (FIB, EBL). These substrates can then be used to 
display a wide range of different receptor ligands in a highly controlled manner - alone or in 
combination with other cell surface receptors. We demonstrate the usefulness of the platform to 
study different cell types, namely cancer cells and cardiomyocytes. Our findings further show that 
different receptor types vary strongly in their clustering behaviour; this demonstrates that previous 
findings from studies employing biomimetic arrays to study RGD/αvβ3 integrin interactions at the 
nanoscale are not universally applicable. Therefore, further work is needed to investigate nanoscale 
organisation for different receptors and receptor combination in detail. By providing nanoscale 
spatial resolution, single-molecule control, and multivalent capability, we believe the DNA origami 
biomimetic nanoarrays presented here are the ideal platform for such studies.
Experimental Methods and Materials 
Synthesis of DNA Origami. 
DNA origami was assembled by combining M13mp18 (5 nM) and staple strands (50 nM) in 50 μL 
of TAE buffer with 12.5 mM Mg2+ (DNA sequences can be obtained at 20). M13mp18 is a bacteria 
phage vector strand with 7249 bases long. An appropriate quantity of ions, such as magnesium here, 
or sodium, are required to efficient DNA hybridization. This acts to equilibrate electrostatic 
repulsion between highly negatively charged DNAs molecules. An amount of 12.5 mM Mg2+ 
sufficient to achieve a high yield of DNA origami and limit any aggregation effects. DNA origami 
are synthesised by annealing from an initial temperature of 94 °C to completely melt all dsDNA. 
Temperature step-controlled annealing was carried out in a PCR machine. Samples were cooled 
from 94 to 65 °Cat a rate of ~0.3 °C per minute. A cooling rate of 0.1 °C per minute is employed 
from 65 °C to room temperature. The self-assembled DNA origami were then purified using 
Millipore Amicon Ultra 100 kDa spin columns in a centrifuge at 2000 rcf for 6 min, three times, to 
remove excess staple strands. DNA origami were adjusted to a concentration ~20 nM and stored in 
Lo-Bind Eppendorf tubes at 4 OC. A NanoDrop spectrophotometer is used to detect the approximate 
concentration of DNA origami products based on the constant of a molecular weight of 330 g/mol 
per base and an extinction coefficient = 33 mg/mL for A260 = the actual result is close to the 
estimated numbers. To ensure efficient assembly and labelling of DNA origami with peptide 
conjugates, unmodified staple strands and amino anchors were added at a 5× excess to the 
M13mp18 backbone and peptide conjugates were added at a 10× excess.
AFM Characterization of DNA Origami. 
AFM (Bruker, Dimension Icon) was used to image the DNA origami structures. DNA origami was 
cast on either silicon dioxide, glass, or mica surfaces for imaging. The DNA origami solution is 
diluted by TAE buffer with 30 mM MgCl2 to around 1 nM in order to get a good separation of the 
DNA nanostructures once immobilized on surface. Magnesium is required in the procedure as an 
ion charged bridge, immobilizing DNA origami to the substrate surfaces. Mica samples were 
cleaved twice by solid scotch tape immediately prior casting. 5 μL of diluted DNA origami solution 
was directly deposited on freshly cleaned mica and left to adsorb on the surface for 2 min. 
Subsequently, the substrate was washed by distilled water to remove non-adsorbed origami and 
then blown dry by compressed air. Silicon nitride ScanAsyst-Air tips with 0.4 N/m spring constant 
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were used to scan the sample by AFM under ScanAsyst Mode. A resolution of 512 pixels per line 
with 1 Hz scan rate was chosen for appropriate imaging of the DNA nanostructure.
The highly hydrophobic hexamethyldisilazane (HMDS) layer on EBL patterned surfaces made it 
very difficult to accurately track the surface when scanning in air. Therefore, to characterise DNA 
origami on the EBL nanopattern, AFM characterisation was carried out in fluid tapping mode. All 
samples were imaged in 5mM Tris, pH 8.3, 40mM MgCl2. Silicon nitride ScanAsyst-Fluid+ with 
0.7 N/m spring constant were used at a resolution of 512 pixels per line and a 1Hz scan rate. 
Amplitude setpoint and gain were optimised for each sample and tip.
Modifications of DNA Origami. 
Peptide A20FMDV2 was assembled on DNA origami using the maleimide−thiol linkage on ssDNA 
complementary to sticky-ends. The numbers of peptides on a single origami depends on how many 
complementary sticky-ends that origami has. Up to 18 positions were chosen in this study (see 
modified sequences in supplementary information). Commercially available protected maleimide 
modified ssDNA need to be deprotected before conjugation. 50 nmoles of the protected maleimide 
modified ssDNA was freeze-dried at first. Deprotection and conjugation will be inefficient in the 
presence of water. Freeze-dried samples were washed adding 2 mL of anhydrous acetonitrile, and 
the solvent was evaporated by a rotary evaporator. Two millilitres of anhydrous toluene was added 
to the vial, mixed, and then evaporated. This rinsing procedure was repeated three times. After the 
second evaporation, toluene was added and heated to 90 °C for 4 h to deprotect the maleimide 
modifier. After incubation, the toluene was evaporated. The vial containing the deprotected 
maleimide-modified ssDNA was immediately mixed with the reduced peptide. The thiol group on 
the cysteine of the peptide needed to be reduced from the oxide form right before conjugation. The 
conjugation reaction occurs after the mixing. The mixture was put on a shaker for 1 h to complete 
the conjugation. Peptide−ssDNA conjugation was validated and purified by reversed-phase HPLC 
(RP-HPLC) with TEAA buffer (triethyl amine acetic acid). Purified products were freeze-dried and 
resuspended in TAE buffer. Peptide−ssDNA conjugation was mixed with staple strands and 
M13mp18, and standard DNA-origami synthesis was carried out. A20FMDV2 is a linear peptide 
with 21 amino acid. Heating up to 94 °C will not affect the structure and function of this peptide. 
Epidermal growth factor (EGF) was modified on DNA origami via streptavidin−biotin conjugation. 
The EGF was biotinylated and assembled with streptavidin which is commercially available. 
Streptavidin-modified EGF was attached on origami structure via incubation with DNA origami 
solution which have biotinylated sticky ends. AFM characterization was carried out to confirm the 
EGF modification.
For cRGDfC peptides, conjugation to ssDNA was performed through UV mediated thiol-ene 
reaction, via a sulfhydryl group on the peptides and a thiol group on acrydite modified ssDNA 
(Integrated DNA Technologies). Peptides were diluted to 100 µM in H2O containing 100× TCEP 
pH 7.0, to reduce any disulfide bonds and present the cysteine groups for conjugation.  Peptides 
were then mixed with the acrydite modified ssDNA at a final concentration of 20 µM and 200 µM, 
respectively. Reactions were carried out in 120mM Tris buffer with 11 µM photoinitiator (2-
hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone). Samples were exposed to 260 nm UV 
light for 1 hour and the conjugates were purified by RP-HPLC and freeze drying, as described 
above.
Fabrication of FIB and EBL Substrates
Fabrication of the FIB substrates was carried out as previously described 36. Briefly, Glass 
coverslips were cleaned in Piranha solution before chromium and gold were evaporated on the 
surface in 2 nm and 8 nm thick layers (respectively). Substrates were then baked on a hotplate at 
300 °C for 15 minutes. 200 × 200 nm squares were then milled into the substrate using the FIB over 
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an array of a desired size. Prior to cross-linking DNA origami, substrates were cleaned using oxygen 
plasma for 5 minutes (Harrick, 18W, room air).
Further substrates were produced by direct write EBL on coverslips. Coverslips were solvent 
cleaned in an ultrasonic bath (acetone followed by methanol, IPA, and water) and dehydrated in a 
180C oven overnight. An oxygen plasma treatment for 60s at 100W power prepared the surface for 
silane deposition, which was done from HMDS vapour in a closed container at 150 C. A 950k 
molecular weight poly(methyl methacrylate) (PMMA) film was spin coated on the coverslips at 5k 
rpm, followed by a short solvent bake on a 180C hotplate for 30s. A 10nm aluminium charge 
conduction layer was evaporated on the coverslips, and they were mounted on a 4-inch silicon wafer 
for EBL processing using crystalbond 555 adhesive. EBL exposure was carried out as described 
previously39 to define arrays of 200nm and 300nm pitch holes, diameter 150nm in the PMMA layer. 
After exposure, the aluminium charge conduction layer was removed in a 2.6% TMAH solution 
(MF-CD26) for 30s followed by water rinse. The surface roughness for both kind of patterned 
surfaces was calculated from AFM topographical heights (Z) by measuring the root mean square 𝑅𝑞
  The FIB and EBL substrates exhibited Rq values of , 3.2 ± 0.1 and 0.7 ± 0.1nm = ∑𝑍𝑖2𝑁
respectively.  
DNA Origami Patterning and Cross-linking. 
For patterning of DNA origami FIB nanofabricated substrates, 60 μL of 1nM of DNA origami were 
incubated on the surface for 1.5 hours in Tris buffer (5 mM; pH 8.3) with 30 mM MgCl2. Substrates 
were placed in a six-well plate with a moist Kimwipe to prevent dewetting and agitated on a shaker. 
Samples were then washed with Tris buffer (5 mM; pH 8.3) containing 30 mM MgCl2 A 0.01% 
solution of carboxyethylsilane (CTES) and incubated for 2 min on a shaker. The buffer was then 
exchanged for MOPS buffer (10 mM; pH 8.0) with 30 mM MgCl2). The initial wash with MOPS 
buffer removed all primary amines from the Tris washes ahead of cross-linking. Next, the MOPS 
buffer was exchanged with an equal volume of MOPS buffer, pH 8.0, containing 100 mM EDC (1-
ethyl 3-(3-(dimethylamino)propyl)carbodiimide), and 50 mM sulfo-NHS (N-
hydroxysulfosuccinimide). Samples were incubated for 10 minutes at room temperature with gentle 
agitation. Finally, samples were then washed with the MOPS buffer without MgCl2 and rinsed with 
DPBS containing 125 mM NaCl. PBS precipitates with Mg and should remove all non-covalent, 
physisorbed origami structures. Origami positioning was verified under AFM.
For patterning of DNA origami on e-beam patterned substrates, patterned substrates were first 
developed in a 2:1 solution of propanol-2:methyl isobutyl ketone for 60 seconds at 23 °C, followed 
by a 30 seconds wash in 100% propanol-2. DNA origami binding sites were then etched using 
oxygen plasma treatment (100W, 70 seconds, room air) followed by silanisation with 0.1% CTES 
in Tris buffer (5 mM, pH 8.0). The PMMA resist was then removed by immersion in NMP at 50 
°C and sonicated or 10 minutes. DNA Origami were incubated for 1 hour at room temperature at a 
concentration of 1 nM in Tris buffer (5 mM, pH 8.3, 50 mM MgCl2, see supplementary methods 
for more information on placement conditions). Due to the hydrophobic nature of the HMDS layer 
and the size of the patterned area, 100 μL of origami solution was required to cover the surface 
sufficiently.  Samples were then washed with MOPS buffer (10 mM, pH 8.1, 50 mM MgCl2) to 
remove primary amines, followed by a wash with MOPS buffer (10 mM, pH 8.1, 50 mM MgCl2) 
containing 50 mM EDC and 25 mM sulfo-NHS. Finally, samples were then washed with the MOPS 
buffer without MgCl2and rinsed with DPBS containing 125 mM NaCl. Before AFM 
characterisation, samples were placed into deionised H2O.
Cancer Cell-Spreading Study.
Cells were grown at 37 °C and 8% (v/v) carbon dioxide/air condition in a humidified incubator. Cells 
were maintained as adherent monolayers on tissue culture plastic. The growth medium contained 
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DMEM accompanied by 10% FBS. Cells were sub-cultured approximately every 3 days. After 
incubation with 0.25% (w/v) trypsin/EDTA solution, adhered cells were removed from culture plastic 
and neutralized by adding three folds of growth medium. Cells were then suspended to fresh tissue 
culture flasks with fresh growth medium. Cells were removed from tissue culture plastic by trypsin, 
neutralized, pelleted, and resuspended in fresh growth medium. The substrates were blocked with 1% 
BSA before cells plating. Growth medium (2 mL) was added to each well and then incubated for 1.5 
h. The substrates were carefully washed by PBS twice to remove non-adhered cells. The patterned 
area with cells was imaged using DIC to observe the cell behaviours. ImageJ was used for counting 
the cell numbers and average cell area analysis. For this outline of cells were drawn manually after 
thresholding. The combined cell area were then measured and divided by the cell numbers.
Cardiomyocyte Isolation and Culture
Neonatal rat cardiomyocytes were prepared as previously described 33. Briefly, newborn rat hearts 
were dissected into ice-cold ADS buffer (116 mM NaCl, 20mM Hepes, 0.8 mM NaH2PO4, 5.6 mM 
glucose, 5.4 mM KCL, 0.8 mM MgSO4) and washed once with ADS buffer. The ADS buffer was 
then removed and hearts were incubated with of 5ml enzyme solution in ADS (ES, 246U 
collagenase and 0.6 mg pancreatin/mL), for 5 min, at 37 °C under vigorous shaking. Tissues were 
then triturated with a pipette and the supernatant was discarded. This step was followed by 5-6 
digests, until hearts were completely digested. Each time 5ml fresh ES was added to the hearts and 
incubated 15 min at 37 °C, under shaking. Hearts were pipetted up and down 30 times using a 
pasteur pipette. The supernatant was then transferred into plating medium (65% DMEM, 17% 
M199, 10% Horse Serum, 5% FCS, 2% Glutamax, 1% Penecillin/Streptamycin (P/S)). Two digests 
each were combined in one tube with 20 ml plating medium, then cleared through a 100 mm cell 
strainer and spun down at 1200 rpm for 5 min at RT, before resuspended in 10 ml plating medium. 
Cells were pooled together and preplated for 90 min to enrich the cardiomyocytes. Cardiomyocytes 
were then plated onto the respective substrates in serum free medim (70% DMEM, 22% M199, 5% 
FCS, 2% Glutamax, 1% Penicillin/ Streptamycin (P/S)). Medium was changed the next day to 
serum free maintenance medium (78% DMEM, 19% M199, 2% horse serum, 2% Glutamax, 1% 
P/S).
Immunofluorescence 
Immunofluorescent investigations were carried out as described previously33. Briefly cells were 
fixed with 4% paraformaldehyde for 10 minutes followed by a wash with PBS. Cells were then 
permeabilised with 0.2% Triton-X for 5 minutes followed by additional PBS washes. Nonspecific 
binding was blocked with a 1-hour incubation in 5% BSA before incubation with Alexa 488 labelled 
phalloidin and DAPI for 1 hour at room temperature to visualise F-actin and cell nuclei, 
respectively. Substrates were washed with PBS (3 × 5 minutes) and mounted on a coverslip in 
mowiol mounting medium.
Statistical Analysis
All statistical analysis was carried out using Graphpad Prism 8. For random origami experiments, 
a one-way ANOVA with Turkey’s correction for multiple comparisons was used to test for 
significant differences. For nanopatterned origami experiments, statistical analyses were carried out 
using a two-way ANOVA with a Turkey’s correction for multiple comparisons.
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Figure Legends:
Figure 1: The three linker chemistries used to conjugate ligands to DNA origami. a) Streptavidin-
biotin reaction. DNA origami were labelled with biotin and then streptavidin labelled EGF was 
incubated with labelled origami in solution. b) The first thiol-ene strategy utilised a free thiol on 
the A20FMDV2 peptide and maleimide modified ssDNA. c) The second thiol-ene strategy utilised 
a free thiol on the cRGDfC peptide and an acrydite modified ssDNA.
Figure 2: Schematic of functionalised DNA origami: a) DNA origami with peptide and EGF 
modification. Peptide, EGF and amino anchor modifications were positioned along the inner and 
outer edges of the DNA origami, and in-plane to the DNA nanostructure; this  ensure the availability 
of the ligands regardless to the orientation of the DNA origami once immobilized on surfaces. b) 
AFM characterisation of EGF functionalised DNA origami. c) zoom-in AFM image of EGF 
modified DNA origami. d) Schematic of DNA origami functionalised with 18 cRGDfC Peptides. 
e) AFM characterisation of peptide modified DNA origami. f) zoom-in AFM characterisation of 
peptide functionalised DNA origami.
Figure 3: Schematics of FIB: a) and E-beam b) nanopattern fabrication. c) Covalent immobilisation 
of DNA origami via carbodiimide reaction chemistry between amino modifications on the central 
void within the DNA origami and carboxylic acid silane. Characterisation of successful cross-
linking of origami to the FIB d) and E-beam e) nanopatterns was carried out with AFM.
Figure 4: Cancer cell investigation on patterned DNA origami nanoarrays: a) Schematic of cell 
investigation; b) A375P cell-spreading study on patterned DNA origami substrates with 300 nm 
spacing include DIC images of cell spreading on different substrates (peptide:EGF=1:1, 
peptide:EGF=3:1 and peptide:EGF=3:3) with 6× zoom-in inset images, and fluorescent staining 
images with DAPI (blue), actin (red) and pTyr (green). 
Figure 5: Verification of neonatal rat cardiomyocyte (NRC) cell adhesion and spreading mediated 
by randomly positioned DNA origami functionalised with 0 a), 6 b), 12 c) and 18 d) cRGDfC 
peptides; this corresponds to peptide distances of  60, 30, and 20nm, respectively.  Insets display 
the DNA origami design used a given condition. N numbers represent the number of cells. f) AFM 
characterisation of 2nM DNA origami cast randomly on SiO2 substrates. Fluorescent channels in 
a-d represent F-actin (green) and DAPI (blue). p values from ANVOA with Tukey correction for 
multiple comparisons: ***=p<0.001, ****=p<0.0001.
Figure 6: Increasing global and local ligand concentration mediates NRC attachment and spreading. 
a) AFM images of 200nm and 300nm DNA origami spacing configurations (far left). DAPI (blue) 
and F-actin (green) staining was used to evaluate cell area b) and integrated F-actin intensity c). p 
values from ANVOA with Tukey correction for multiple comparisons: ** = p<0.01, *** = p 
<0.001, **** = p<0.0001. Box and whisker diagrams: Box limits represent the 25th to 75th 
percentiles and whiskers represent 1.5× interquartile range. N-numbers represent the number of 
cells.
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Figure 1
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Figure 2
Figure 3
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Figure 4
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Figure 5
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Figure 6
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TOC graphic
DNA Origami nanoarrays with cell surface receptor ligands for cellular studies of human 
cutaneous melanoma cells and neonatal rat cardiomyocytes. 
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